Genome-wide association study of germline variants and breast cancer-specific mortality
- PMID: 30787463
- PMCID: PMC6461853
- DOI: 10.1038/s41416-019-0393-x
Genome-wide association study of germline variants and breast cancer-specific mortality
Abstract
Background: We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry.
Methods: Meta-analyses included summary estimates based on Cox models of twelve datasets using ~10.4 million variants for 96,661 women with breast cancer and 7697 events (breast cancer-specific deaths). Oestrogen receptor (ER)-specific analyses were based on 64,171 ER-positive (4116) and 16,172 ER-negative (2125) patients. We evaluated the probability of a signal to be a true positive using the Bayesian false discovery probability (BFDP).
Results: We did not find any variant associated with breast cancer-specific mortality at P < 5 × 10-8. For ER-positive disease, the most significantly associated variant was chr7:rs4717568 (BFDP = 7%, P = 1.28 × 10-7, hazard ratio [HR] = 0.88, 95% confidence interval [CI] = 0.84-0.92); the closest gene is AUTS2. For ER-negative disease, the most significant variant was chr7:rs67918676 (BFDP = 11%, P = 1.38 × 10-7, HR = 1.27, 95% CI = 1.16-1.39); located within a long intergenic non-coding RNA gene (AC004009.3), close to the HOXA gene cluster.
Conclusions: We uncovered germline variants on chromosome 7 at BFDP < 15% close to genes for which there is biological evidence related to breast cancer outcome. However, the paucity of variants associated with mortality at genome-wide significance underpins the challenge in providing genetic-based individualised prognostic information for breast cancer patients.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- UM1 CA164973/CA/NCI NIH HHS/United States
- R01 CA176785/CA/NCI NIH HHS/United States
- RP-PG-1214-20016/DH_/Department of Health/United Kingdom
- K07 CA092044/CA/NCI NIH HHS/United States
- U01 CA116167/CA/NCI NIH HHS/United States
- R01 CA128978/CA/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- U19 CA148112/CA/NCI NIH HHS/United States
- U01 CA098758/CA/NCI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- MR/M012190/1/MRC_/Medical Research Council/United Kingdom
- RP-PG-0707-10031/DH_/Department of Health/United Kingdom
- UM1 CA164917/CA/NCI NIH HHS/United States
- U01 CA199277/CA/NCI NIH HHS/United States
- U01 CA179715/CA/NCI NIH HHS/United States
- R01 CA128931/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- U54 CA156733/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- UM1 CA164920/CA/NCI NIH HHS/United States
- MR/N003284/1/MRC_/Medical Research Council/United Kingdom
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- R01 CA097396/CA/NCI NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- R01 CA058860/CA/NCI NIH HHS/United States
- 16459/CRUK_/Cancer Research UK/United Kingdom
- HHSN268201100003C/WH/WHI NIH HHS/United States
- G1000143/MRC_/Medical Research Council/United Kingdom
- G0700491/MRC_/Medical Research Council/United Kingdom
- P50 CA058223/CA/NCI NIH HHS/United States
- 14136/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148537/CA/NCI NIH HHS/United States
- R01 CA116167/CA/NCI NIH HHS/United States
- R01 CA177150/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- HHSN271201100004C/AG/NIA NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- 16563/CRUK_/Cancer Research UK/United Kingdom
- U01 CA063464/CA/NCI NIH HHS/United States
- R01 CA077398/CA/NCI NIH HHS/United States
- R01 CA054281/CA/NCI NIH HHS/United States
- R01 CA132839/CA/NCI NIH HHS/United States
- U01 CA058860/CA/NCI NIH HHS/United States
- U19 CA148065/CA/NCI NIH HHS/United States
- 10119/CRUK_/Cancer Research UK/United Kingdom
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- R01 CA192393/CA/NCI NIH HHS/United States
- P30 CA006927/CA/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- U01 CA164973/CA/NCI NIH HHS/United States
- R01 CA140286/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 18832/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
